Danielle Valletti, Assistant Editor

Pharmacists play a vital role in identifying and managing primary immunodeficiency diseases, enhancing patient outcomes through immunoglobulin therapy and education.

FDA approves a new quadruplet therapy for newly diagnosed multiple myeloma, enhancing treatment options for patients ineligible for stem cell transplant.

Pharmacists play a vital role in supporting multiple sclerosis patients by addressing medication challenges, educating on treatments, and navigating insurance hurdles.

Explore how pharmacists enhance access to care for multiple sclerosis patients, tackling barriers in diagnosis, treatment, and patient education.

The FDA expands Cerezyme's approval for treating non-CNS symptoms of type 3 Gaucher disease, marking a significant advancement in patient care.

Pharmacists play a crucial role in educating patients with multiple sclerosis about treatment options, adverse effects, and navigating insurance challenges.

FDA's draft guidance on MRD and CR as end points accelerates multiple myeloma therapy approvals, enhancing patient access and transforming oncology practices.

Innovative immunotherapy strategies, like linvoseltamab, show promise in treating multiple myeloma, potentially reducing reliance on traditional transplants.

Pharmacists enhance care for multiple sclerosis patients by improving access, education, and adherence, ensuring effective treatment through collaboration with healthcare teams.

Explore the evolving landscape of myelofibrosis treatment, focusing on personalized therapy, JAK inhibitors, and the role of pharmacists in patient care.

Jordan Harper, DMD, discusses innovative fluoride-free toothpaste tablets with hydroxyapatite, offering effective oral care solutions for all patients.

FDA grants priority review for gedatolisib, a promising treatment for advanced HR+/HER2– breast cancer, showcasing significant efficacy in recent trials.

Discover how hydroxyapatite toothpaste tablets revolutionize oral care with eco-friendly, effective, and gentle alternatives to traditional fluoride toothpaste.

New research reveals circulating tumor cells can predict patient response to tarlatamab in small cell lung cancer, enhancing personalized treatment strategies.

Discover how ENAMEL revolutionizes oral care with eco-friendly, waterless toothpaste tablets made from clean, natural ingredients.

New research reveals PUF60's critical role in triple-negative breast cancer, highlighting RNA splicing as a promising therapeutic target for oncology.

Innovative digital twin technology revolutionizes brain cancer treatment by predicting tumor metabolism and personalizing therapies for better patient outcomes.

Explore the differences between oral and injectable semaglutide for weight management, focusing on adherence, adverse effects, and patient preferences.

New research reveals a gut bacteria-derived molecule that enhances lung cancer immunotherapy, potentially improving outcomes for patients with limited treatment options.

Pitavastatin shows promise as a novel treatment for triple-negative breast cancer, enhancing chemotherapy efficacy and targeting cancer cell survival pathways.

Pharmacists play a vital role in mental health care, enhancing treatment continuity and bridging gaps between mental and physical health for patients with serious mental illness.

The FDA approves Naox Link, a groundbreaking in-ear EEG device, transforming brain monitoring and enhancing neurologic care for patients and pharmacists.

Recent studies reveal that weight recovery in anorexia nervosa does not ensure muscle restoration, highlighting the need for comprehensive recovery strategies.

New dietary guidelines emphasize higher protein intake, reduced added sugars, and avoidance of ultra-processed foods to combat chronic diseases.

The role of cancer-associated fibroblasts in non–small cell lung cancer (NSCLC) drug resistance highlights innovative strategies to enhance treatment efficacy.

Explaining megestrol acetate's dual role in managing symptoms and enhancing treatment efficacy for estrogen receptor–positive breast cancer.

Toothpaste tablets revolutionize oral care with eco-friendly, convenient options, while pharmacists guide consumers in making informed choices for dental health.

GoodRx enhances access to semaglutide with affordable cash pricing, revolutionizing obesity treatment and supporting patients in weight management.

FDA considers relaxing dietary supplement warning labels, raising concerns about consumer safety and informed decision-making among users.

Expert highlights the critical need to manage skin toxicities in oncology, ensuring effective cancer treatments while addressing patient well-being and adherence.